Evidence map›Paper›PMID 31464593›Full record

Observational studyBMC infectious diseases2019

The utility of endotracheal aspirate bacteriology in identifying mechanically ventilated patients at risk for ventilator associated pneumonia: a single-center prospective observational study.

Ekaterina Kabak, Jana Hudcova, Zoltán Magyarics, Lukas Stulik, Marie Goggin, Valéria Szijártó, Eszter Nagy, Chris Stevens

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Le infezioni in medicina · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Extensive microbiological respiratory tract specimen characterization in critically ill COVID-19 patients.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2021
    Observational
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ekaterina KabakPreviously Arsanis Biosciences GmbH, Vienna, Austria.
Jana HudcovaLahey Hospital and Medical Center, Burlington, MA, USA.
Zoltán MagyaricsX4 Pharmaceuticals Inc, Cambridge, MA, USA. zoltan.magyarics@x4pharma.com.
Lukas StulikX4 Pharmaceuticals Inc, Cambridge, MA, USA.
Marie GogginLahey Hospital and Medical Center, Burlington, MA, USA.
Valéria SzijártóCEBINA (Central European Biotech Incubator and Accelerator) GmbH, Vienna, Austria.
Eszter NagyCEBINA (Central European Biotech Incubator and Accelerator) GmbH, Vienna, Austria.
Chris StevensPreviously Arsanis Biosciences GmbH, Vienna, Austria.
Epix Pharmaceuticals (United States) · USLahey Medical Center · US

Funding

Österreichische Forschungsförderungsgesellschaft (AT) 845382
6 · The paper itself

Abstract

backgroundVentilator-associated pneumonia (VAP) is a well-known, life-threatening disease that persists despite preventative measures and approved antibiotic therapies. This prospective observational study investigated bacterial airway colonization, and whether its detection and quantification in the endotracheal aspirate (ETA) is useful for identifying mechanically ventilated ICU patients who are at risk of developing VAP.

methods240 patients admitted to 3 ICUs at the Lahey Hospital and Medical Center (Burlington, MA) between June 2014 and June 2015 and mechanically ventilated for > 2 days were included. ETA samples and clinical data were collected. Airway colonization was assessed, and subsequently categorized into "heavy" and "light" by semi-quantitative microbiological analysis of ETAs. VAP was diagnosed retrospectively by the study sponsor according to a pre-specified pneumonia definition.

resultsPathogenic bacteria were isolated from ETAs of 125 patients. The most common species isolated was S. aureus (56.8%), followed by K. pneumoniae, P. aeruginosa, and E. coli (35.2% combined). VAP was diagnosed in 85 patients, 44 (51.7%) with no bacterial pathogen, 18 associated with S. aureus and 18 Gram-negative-only cases, and 5 associated with other Gram-positive or mixed species. A higher proportion of patients who were heavily colonized with S. aureus developed VAP (32.4%) associated with S. aureus compared to those lightly colonized (17.6%). The same tendency was seen for patients heavily and lightly colonized with Gram-negative pathogens (30.0 and 0.0%, respectively). Detection of S. aureus in the ETA preceded S. aureus VAP by approximately 4 days, while Gram-negative organisms were first detected 2.5 days prior to Gram-negative VAP. VAP was associated with significantly longer duration of mechanical ventilation and hospitalization regardless of microbiologic cause when compared to patients who did not develop VAP.

conclusionsThe overall VAP rate was 35%. Heavy tracheal colonization supported identification of patients at higher risk of developing a corresponding S. aureus or Gram-negative VAP. Detection of bacterial ETA-positivity tended to precede VAP.

Indexed as

AdultAgedAnti-Bacterial AgentsBacteriaFemaleHumansIntensive Care UnitsIntubation, IntratrachealLength of StayMaleMiddle AgedPneumonia, BacterialPneumonia, Ventilator-AssociatedProspective StudiesRespiration, ArtificialTracheaAnti-Bacterial AgentsEndotracheal aspirateGram-negative pathogensProspective studyStaphylococcus aureusVentilator-associated pneumonia

Identifiers

PMID31464593
PMCPMC6716855
OpenAlexW2970927301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.